IMCAS Exclusive Interview, recorded during IMCAS Asia 2025.

"What's fascinating about the GLP/GIP combination medications is that they may potentially have some modulation of the degree of lean body mass loss."

What does the future hold for GLP-1 and GIP therapies, and what might their impact extend beyond weight management?

In this episode, we speak with Dr. Roger Chen, an endocrinologist from Sydney, specializing in diabetes, thyroid, adrenal, and pituitary disorders, and andrology. As a clinician and educator coordinating the endocrinology unit of the Master of Internal Medicine for the University of Sydney and teaching at the University of New South Wales, Dr. Chen brings both a practical and forward-looking perspective to one of the most rapidly evolving areas of medicine.

Together, we explore how GLP-1 and GIP therapies are changing the way clinicians approach the management of obesity, as well as the questions that remain around their longer-term effects. We also look beyond weight loss to emerging research into the dermatologic and aesthetic effects associated with these therapies, including the potential impact on lean body mass, and what this evolving field may mean for patients and practitioners alike.

Truthful, clinical, and remarkably optimistic, this conversation offers a glimpse into a new era of weight management while keeping sight of what ultimately matters: the everyday work of helping people live healthier, better lives.

IMCAS Exclusive Interview, recorded during IMCAS World Congress 2025.

"There's no cookbook for the procedures we do. We have to address the pathology and customize the treatment, because no patient is the same."

What separates a safe injectable outcome from a complication? Two of Southeast Asia's leading dermatologists have a clear answer: assessment, product knowledge, and clinical skill. In that order.

Join us for a conversation with Dr. Atchima Suwanchinda, dermatologic surgeon and injectable safety advocate from Bangkok, and Dr. Maria Christina Puyat, dermatologist and regenerative medicine specialist from Manila, two practitioners who have built their careers on anatomy-first principles and evidence-based product selection.

Together, they discuss the three pillars of responsible injectable practice, the rise of social media-driven patient expectations, and what they see going wrong in clinics across their region. They also explore the shift toward regenerative aesthetics, products that don't just add volume, but work with the biology of aging skin to restore function, not just appearance.

Frank, clinical, and at times refreshingly candid, this conversation is a reminder that behind every great aesthetic outcome is a practitioner who went back to the basics, and stayed there.

IMCAS Exclusive Interview, recorded during IMCAS World Congress 2025.

"It's using light to heal. There's no needles. It's a very natural process. And it could be the most scientific thing we have in all aesthetic medicine."

What does it take to turn a chance encounter in medical school into a 20-year career at the frontier of laser medicine? Join us for a conversation with Dr. Jill Waibel, the dermatologist who pioneered the use of fractional lasers on burn and trauma patients, and who has since become one of the most recognized voices in scar treatment worldwide.

Dr. Waibel walks us through her clinical approach to scar treatment across all skin types, her dinner-menu framework for selecting laser modalities, and the discovery of laser-assisted drug delivery that emerged, almost accidentally, on live television. She also addresses the real barriers to care, from reimbursement gaps to the challenges of treating pediatric patients, and shares what she sees coming next in laser technology, from optical coherence tomography to AI-assisted device selection.

Whether you are new to scar treatment or a seasoned laser practitioner, this conversation is a masterclass in precision, adaptability, and the profound impact aesthetic medicine can have beyond cosmetic outcomes.